Literature DB >> 15941153

Early results of metal on metal articulation total hip arthroplasty in young patients.

J A Mohamad1, M K Kwan, A M Merican, A A Abbas, Z H Kamari, M K Hisa, Z Ismail, R M Idrus.   

Abstract

We report our early experience of 20 cases of metal on metal articulation total hip arthroplasty in 19 young patients. Avascular necrosis of the femoral head (63%) was the commonest diagnosis for patients undergoing this procedure, followed by osteoarthritis (21%). In general, most of the patients were young and physically active with an average age of 43.1 years (range, 25 to 58 years). The average follow-up period was 18 months (range, 7 to 46 months). The mean total Harris Hip Score preoperatively and at final follow-up was 31 points and 89 points respectively. The mean total Pain Score improved from an average of 11.5 to 41.1 points at final follow-up. Sixteen (84%) of the patients had a good to excellent hip score. There was one dislocation, which stabilized after reduction and conservative management. One case of early infection underwent a two-staged revision.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15941153

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  4 in total

1.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

Review 2.  [Resurfacing for osteonecrosis of the femoral head].

Authors:  M Akbar; M A Mont; C Heisel; D R Marker; S D Ulrich; T M Seyler
Journal:  Orthopade       Date:  2008-07       Impact factor: 1.087

Review 3.  Metal-on-Metal Bearing: Is This the End of the Line? We Do Not Think So.

Authors:  Henri Migaud; Sophie Putman; Antoine Combes; Charles Berton; Donatien Bocquet; Laurent Vasseur; Julien Girard
Journal:  HSS J       Date:  2012-09-11

4.  Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress.

Authors:  Gerardo Bosco; Giuliano Vezzani; Simona Mrakic Sposta; Alex Rizzato; Garrett Enten; Abdullah Abou-Samra; Sandro Malacrida; Silvia Quartesan; Alessandra Vezzoli; Enrico Camporesi
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.